Immune System News and Research

RSS

Scientists create fluorescent proteins for live cell imaging, biosensor design

Scientists at Carnegie Mellon University's Molecular Biosensor and Imaging Center have developed new "fluorogen activating proteins" (FAPs) that will become a key component of novel molecular biosensor technology being created at Carnegie Mellon.

7 Feb 2008

Vitamin D for cancer

It sounds too good to be true … a little inexpensive pill that could block the development of some cancers, strengthen bones, prevent multiple sclerosis and alleviate winter depression.

7 Feb 2008

Button mushrooms have as much antioxidants as expensive rivals

The humble white button mushroom (Agaricus bisporus) has as much, and in some cases, more anti-oxidant properties than more expensive varieties.

6 Feb 2008

Getting under the skin of HIV, hep C

The University of New South Wales (UNSW) is working towards a new approach to treat people with HIV/AIDS, with a drug which has already shown promise in the laboratory.

5 Feb 2008

Study shows that a key protein appears to enable spread of melanoma to the small intestine

A study by researchers at the John Wayne Cancer Institute at Saint John's Health Center has shown that a receptor protein found on melanoma cells appears to facilitate the disease's spread to the small intestine.

5 Feb 2008

Molecules developed at UB boost vaccine potency

Two novel proteins studied by a University at Buffalo professor of microbiology and immunology appear to have the potential to enhance the production of antibodies against a multitude of infectious agents.

5 Feb 2008

Study finds widespread vitamin and mineral use among cancer survivors, although benefits of such use remain unclear

Use of vitamin and mineral supplements among cancer survivors is widespread, despite inconclusive evidence that such use is beneficial, according to a comprehensive review of scientific literature conducted by researchers at Fred Hutchinson Cancer Research Center and published Feb. 1 in the Journal of Clinical Oncology.

5 Feb 2008

Enbrel shown to significantly reduced levels of C-reactive protein

Amgen and Wyeth Pharmaceuticals, a division of Wyeth have announced findings from a retrospective analysis, which demonstrated that ENBREL reduced C-reactive protein (CRP), a marker of inflammation, in patients with moderate to severe plaque psoriasis following 12 weeks of treatment. Median reduction in CRP levels was 10 times greater in the ENBREL treated group compared to the placebo treated group.

5 Feb 2008

New vaccine for malaria under trial

Trials are underway, funded by the Wellcome Trust, for a new vaccine to combat the most deadly form of malaria.

5 Feb 2008

Genetic mutations in the Toll-like receptor 4 gene increase risk of preterm birth

Genetic mutations in the Toll-like receptor 4 (TLR4) gene appear to have significant association with inflammatory injury to the placenta and developing baby, researchers from the University of Pittsburgh's department of obstetrics, gynecology and reproductive sciences report at the 28th annual meeting of the Society for Maternal-Fetal Medicine.

5 Feb 2008

Novel drug romiplostim significantly improves treatment of dangerous blood disorder

Two clinical trials of the novel drug romiplostim (Nplate) show that it significantly improved platelet levels in patients with chronic immune thrombocytopenic purpura (ITP), a hematologic disorder that can cause uncontrolled bleeding.

5 Feb 2008

Risk factors for severe RSV infection in immunocompromised children

St. Jude Children's Research Hospital investigators and collaborators have shown how to predict if a child who is infected with respiratory syncytial virus (RSV) while being treated for cancer or another catastrophic disease is at high risk for developing severe infection. The finding will help clinicians improve guidelines for managing these infected children.

4 Feb 2008

Resisting lung cancer recurrence - Vaccine booster gives persistent immune response

What if we could prevent cancer recurrence for years after surgery by giving simple recall injections every two or three years? This concept may no longer be a fantasy.

4 Feb 2008

New discoveries on what does and doesn't affect immune system

Scientists know that a number of factors can affect the body's immune system: poor diet, certain steroids, chronic stress. Now researchers at Michigan State University have discovered that an appetite-controlling hormone also affects the immune system, while natural versions of certain steroids do not.

4 Feb 2008

Targeting astrocytes slows progression of Lou Gehrig's disease

In what the researchers say could be promising news in the quest to find a therapy to slow the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, scientists at the University of California, San Diego (UCSD) School of Medicine have shown that targeting neuronal support cells called astrocytes sharply slows disease progression in mice.

4 Feb 2008

Zinc supplementation helps diarrhea symptoms

Diarrhea is a major health problem, especially in the developing world. It is estimated that diarrheal disease is responsible for roughly 21 percent of all deaths in children younger than 5 worldwide.

4 Feb 2008

New discovery, immune cells confront viruses just inside of the lymph node

Vaccines have led to many of the world's greatest public health triumphs, but many deadly viruses, such as HIV, still elude the best efforts of scientists to develop effective vaccines against them. An improved understanding of how the immune system operates during a viral infection is critical to designing successful anti-virus vaccines.

4 Feb 2008

Immune System News and Research

Scientists create fluorescent proteins for live cell imaging, biosensor design

Vitamin D for cancer

Button mushrooms have as much antioxidants as expensive rivals

Getting under the skin of HIV, hep C

Study shows that a key protein appears to enable spread of melanoma to the small intestine

Molecules developed at UB boost vaccine potency

Study finds widespread vitamin and mineral use among cancer survivors, although benefits of such use remain unclear

Enbrel shown to significantly reduced levels of C-reactive protein

New vaccine for malaria under trial

Genetic mutations in the Toll-like receptor 4 gene increase risk of preterm birth

Novel drug romiplostim significantly improves treatment of dangerous blood disorder

Risk factors for severe RSV infection in immunocompromised children

Resisting lung cancer recurrence - Vaccine booster gives persistent immune response

New discoveries on what does and doesn't affect immune system

Targeting astrocytes slows progression of Lou Gehrig's disease

Zinc supplementation helps diarrhea symptoms

New discovery, immune cells confront viruses just inside of the lymph node

Researchers examine immune cells where HIV can lie dormant, possible treatments

Scientists recreate rhinovirus infection in mice - hope of new asthma treatments

Protein, macrophage migration inhibitory factor predicts heart attack response and cardiac damage

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News